Kite Pharma
2009
FOUNDED
M&A
STATUS
501-600
EMPLOYEES
M&A
LATEST DEAL TYPE
$12B
LATEST DEAL AMOUNT
Description
Developer of active immunotherapies for cancer intended to cure cancer. The company is engaged in developing engineered cell therapies that express either a chimeric antigen receptor (CAR) or a T cell receptor (TCR), depending on the type of cancer. It's dual platform has the potential to change the paradigm of cancer therapy and address both hematological and solid tumor cancers.
Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Parent Company
Primary Office
- 2400 Broadway
- Santa Monica, CA 90404
- United States
+1 (310) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Kite Pharma’s full profile, request a free trial.
Kite Pharma Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 03-Oct-2017 | $12B | 00000 | 0000 | Completed | Profitable |
| 4. Secondary Transaction - Open Market | 01-Apr-2015 | 00000 | Completed | Generating Revenue | ||
| 3. IPO | 20-Jun-2014 | 00000 | 00000 | 00000 | Completed | Generating Revenue |
| 2. Mezzanine | 28-Apr-2014 | $50M | $85M | Completed | Clinical Trials - Phase 2 | |
| 1. Early Stage VC (Series A) | 15-May-2013 | $35M | $35M | 00000 | Completed | Clinical Trials - Phase 2 |
Kite Pharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Kite Pharma Competitors (32)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Carisma Therapeutics | Venture Capital-Backed | Philadelphia, PA | 0000 | 00000000000 | 0000 | |
| 000000000 | Formerly VC-backed | Vancouver, Canada | 000 | 00000 | 00000000 | 00000 |
| 000000 | Venture Capital-Backed | Utrecht, Netherlands | 00.000 | 00000000000 | 00.000 | |
| 00000000 | Formerly VC-backed | Munich, Germany | 000.00 | 000000&0 | 000.00 | |
| 00000000 | Venture Capital-Backed | Tübingen, Germany | 000 | 00000 | 00000000000 | 00000 |
Kite Pharma Investments & Acquisitions (6)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 | 28-Aug-2019 | 00000 00000 00 | 0000 | Drug Discovery | |
| 000000 | 19-Jul-2018 | 000000000 00000000 | Biotechnology | ||
| 0000000 (000,000 0 | 12-Apr-2018 | 000000000 00000 00 | 00000 | Buildings and Property | 000000 000 00.0 |
| 00000 0000 0000000 | 01-Apr-2017 | 00000 0000000 | Drug Discovery | 0000 0000000000 00 | |
| Cell Design Labs | 16-Jun-2016 | Later Stage VC | 000 | Biotechnology | 0000 0000000000 00 |
Kite Pharma Former Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Alta Partners | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Arie Belldegrun | Angel (individual) | Minority | 000 0000 | 000000 0 | ||
| BB Biotech | Asset Manager | Minority | 000 0000 | 000000 0 | ||
| Commercial Street Capital | Other | Minority | 000 0000 | 000000 0 | ||
| Foresite Capital Management | Growth/Expansion | Minority | 000 0000 | 000000 0 |
Kite Pharma Executive Team (19)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Prentice Curry | Senior Vice President, Quality and Compliance | ||
| Adrian Bot Ph.D | Vice President, Scietific Officer | ||
| Christi Shaw | Chief Executive Officer & Board Member |
16 Former Executives
You’re viewing 3 of 19 executives. Get the full list »Kite Pharma Board Members (9)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Christi Shaw | Self | Chief Executive Officer & Board Member | 000 0000 | |
| Roy Doumani | Kite Pharma | Independent Director | 000 0000 |
7 Former Board Members
You’re viewing 2 of 9 board members. Get the full list »